What is the Org number of DareMe Drug Discovery Consulting AB?

DareMe Drug Discovery Consulting AB is registered with Bolagsverket / SCB under Org 5594232398.

What is the revenue of DareMe Drug Discovery Consulting AB?

DareMe Drug Discovery Consulting AB reported revenue of SEK 1,1M in 2025.

Who is the chairman of DareMe Drug Discovery Consulting AB?

Nina Elisabeth Carlsson chairs the board of DareMe Drug Discovery Consulting AB, in role since 2023.

Where is DareMe Drug Discovery Consulting AB headquartered?

DareMe Drug Discovery Consulting AB's registered address is Sunnerstavägen 26 L.

Riskpilot← Back to search

Sign inGet full access

DareMe Drug Discovery Consulting AB

ABActive

Org 5594232398Sunnerstavägen 26 L, 756 51 UppsalaResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20230 employees

Overview Financials People & ownership Related companies

Financials

Revenue

SEK millions

EBITDA

SEK millions

Income statement

SEK thousands

Item	2023	2024	2025
Revenue	46	0	1 087
Staff expenses	—	—	—
EBITDA	30	−5	1 077
Depreciation & amort.	−0	−0	−0
EBIT	30	−5	1 077
Net financials	—	—	—
Profit before tax	30	−5	1 078
Tax	−6	−0	−222
Net profit	24	−5	856

Balance sheet

SEK thousands

Item	2023	2024	2025
Total assets	46	44	1 387
Equity	49	44	900
Long-term debt	0	0	0
Short-term debt	3	0	487
Total debt	3	—	487

Financial ratios

5-year trend

EBITDA margin

99.1%

This company

15.8%

Market median

+527% vs market

20232025

Equity ratio

64.9%

This company

38.2%

Market median

+70% vs market

20232025

Return on equity

95.1%

This company

18.4%

Market median

+417% vs market

20232025

Net profit margin

78.7%

This company

8.1%

Market median

+872% vs market

20232025

Asset turnover

0.78×

This company

1.12×

Market median

-30% vs market

20232025

Debt / equity

0.54×

This company

0.62×

Market median

+13% vs market

20232025

Annual reports & filings

Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-02-01 – 2023-12-31
View PDF

DareMe Drug Discovery Consulting AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on DareMe Drug Discovery Consulting AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on DareMe Drug Discovery Consulting AB